Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IBEX Technologies Inc V.IBT

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.


TSXV:IBT - Post by User

Post by guarantor1on Jan 09, 2022 10:56am
145 Views
Post# 34297477

IBEX AGM at the Montreal Airport Marriott, Feb 16

IBEX AGM at the Montreal Airport Marriott, Feb 16

and shareholders are "requested to avoid attending"
(wonder why they aren't doing a "ZOOM" from their Pare HQ, like last year ? )

IBEX TECHNOLOGIES INC.
NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

NOTICE is hereby given that an Annual and Special Meeting of Shareholders (the Meeting”) of IBEX Technologies Inc. (the Corporation”) will be held at Montreal Airport Marriott In-Terminal Hotel 800, Pl Leigh-Capreol, Dorval, QC H4Y 0A4 on Wednesday, February 16, 2022, at 10:00 a.m. (eastern time) for the following purposes:

  1. to receive the consolidated financial statements of the Corporation for the fiscal year ended July 31, 2021,

    together with the auditor’s report thereon;

  2. to elect the directors of the Corporation for the ensuing year;

  3. to appoint PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the auditor of the Corporation and authorize the Board of Directors of the Corporation to set its remuneration;

  4. to consider, and if deemed advisable adopt, a resolution in the form annexed to the Management Proxy Circular as Schedule A, ratifying, confirming and approving the “reload” of 527,008 common shares under the Incentive Stock Option Plan of the Corporation;

  5. to consider, and if deemed advisable to adopt, a resolution in the form annexed to the Management Proxy Circular as Schedule B, confirming an amendment to Article 10 of By-Law No. 1 of the Corporation so as to provide for meetings of the shareholders of the Corporation, and voting thereat, by telephonic, electronic or other communication facility; and

  6. to transact such other business as may properly come before the Meeting or any adjournment thereof.

The Corporation has fixed January 4, 2022 as the record date for the Meeting. Owing to the COVID-19 situation, shareholders are requested to avoid attending the Meeting in person. Shareholders not attending the Meeting in person will be able to participate in the manner to be posted on the Corporation’s website (www.ibex.ca) prior to the meeting.

Shareholders are encouraged to date, sign and return the enclosed form of proxy. Proxies to be used at the Meeting must be deposited with Computershare Investor Services Inc. (Attention: Proxy Department), 100 University Avenue, 8th Floor, Toronto, Ontario M5J 2Y1 prior to 5:00 p.m. (eastern time) on February 14, 2022 or with the Secretary of the Corporation before the commencement of the Meeting or at any adjournment thereof.

By Order of the Board of Directors

(signed) Belinda Franco Secretary

Montreal, Quebec, January 4, 2022


<< Previous
Bullboard Posts
Next >>